Found 11 matching trials
Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery
NAPostoperative new-onset atrial fibrillation (AF) is the most common complic...
Location
National Cardiovascular Center
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
NAPremature ventricular complexes (PVCs) are extra, abnormal heart beats aris...
Location
Westmead Hospital
Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
PHASE4To evaluate the effects of two different antihypertensive medications in th...
Location
GSK Investigational Site
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
PHASE3This study was designed to determine whether treatment with COREG MR is mor...
Location
GSK Investigational Site
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
PHASE4The purpose of this study is to compare the vascular effects of two commonl...
Location
St. Paul Heart Clinic
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
PHASE4This prospective, multicenter, open-label, randomized comparative effective...
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
NAThe CABANA pilot study is designed to test the hypothesis that the treatmen...
Location
Universtity of Alabama Hospital
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
PHASE3This study was designed to determine whether COREG MR is more effective tha...
Location
GSK Investigational Site
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
NAThe (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibri...
Location
Arkansas Cardiology, PA
Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure
PHASE4Metoprolol succinate is a beta1-selective beta-blocker, becoming non-select...
Location
University of Utah